113 related articles for article (PubMed ID: 38835753)
1. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.
Zhang Y; Liu W; Lai J; Zeng H
Front Immunol; 2024; 15():1394438. PubMed ID: 38835753
[TBL] [Abstract][Full Text] [Related]
2. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
[TBL] [Abstract][Full Text] [Related]
3. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
4. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
5. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
6. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
Zou M; Shao Z
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
[TBL] [Abstract][Full Text] [Related]
7. Causal relationship between the immune cells and ankylosing spondylitis: univariable, bidirectional, and multivariable Mendelian randomization.
Qin C; Yu Q; Deng Z; Zhang Y; Chen M; Wang X; Hu T; Lei B; Yan Z; Cheng S
Front Immunol; 2024; 15():1345416. PubMed ID: 38655262
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
[TBL] [Abstract][Full Text] [Related]
9. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
10. Potential drug targets for gastroesophageal reflux disease and Barrett's esophagus identified through Mendelian randomization analysis.
Lin YL; Yao T; Wang YW; Zhou ZX; Hong ZC; Shen Y; Yan Y; Li YC; Lin JF
J Hum Genet; 2024 Jun; 69(6):245-253. PubMed ID: 38429412
[TBL] [Abstract][Full Text] [Related]
11. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.
Zhou S; Tao B; Guo Y; Gu J; Li H; Zou C; Tang S; Jiang S; Fu D; Li J
J Transl Med; 2024 Jun; 22(1):557. PubMed ID: 38858729
[TBL] [Abstract][Full Text] [Related]
12. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
[TBL] [Abstract][Full Text] [Related]
13. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome.
Si S; Liu H; Xu L; Zhan S
Genome Med; 2024 Jun; 16(1):84. PubMed ID: 38898508
[TBL] [Abstract][Full Text] [Related]
15. Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.
Ouyang Y; Chen Y; Chen K; Tang Z; Shi G; Qu C; Zhang K; Yang H
Hum Genomics; 2024 Apr; 18(1):43. PubMed ID: 38659056
[TBL] [Abstract][Full Text] [Related]
16. Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses.
Chen B; Wang L; Pu S; Guo L; Chai N; Sun X; Tang X; Ren Y; He J; Hao N
Sci Rep; 2024 Mar; 14(1):6435. PubMed ID: 38499600
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
[TBL] [Abstract][Full Text] [Related]
18. No Evidence of a Genetic Causal Relationship between Ankylosing Spondylitis and Gut Microbiota: A Two-Sample Mendelian Randomization Study.
Yang M; Wan X; Zheng H; Xu K; Xie J; Yu H; Wang J; Xu P
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839415
[No Abstract] [Full Text] [Related]
19. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
20. No genetic causal association between periodontitis and ankylosing spondylitis: a bidirectional two-sample mendelian randomization analysis.
Han C; Wu D; Yu F; Wang Q; Yang Y; Li Y; Qin R; Chen Y; Xu L; He D
BMC Med Genomics; 2024 May; 17(1):118. PubMed ID: 38698441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
